The arguments for and against rolling out COVID-19 boosters this month
There seems to be no consensus on how and when the United States should go about delivering COVID-19 booster shots to Americans.
On Friday, it was reported that top officials are urging the White House to scale back its plans to make everyone eligible starting Sept. 20. Instead, there's a chance only Pfizer recipients — and even then just a portion — will get their extra doses by that date because there isn't enough data on the Moderna vaccine — which may have more staying power than Pfizer's — and the Johnson & Johnson shot.
Count the nation's top infectious disease expert Dr. Anthony Fauci and former Food and Drug Administration Commissioner Scott Gottlieb among the proponents of boosters, with the hope that a third dose (for Pfizer and Moderna) might be the cap the regimen needs. As Gottlieb explained during a CNBC appearance on Friday, it's possible that the first two doses were administered so closely together that they basically served as two "primes," rather than an initial shot and a booster. The third one, he said, could very well prove more durable, so he's not yet predicting the need for an annual booster.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Others still think it's better to hold off for now. The Atlantic's Katherine Wu writes that most of the experts she's spoken to told her "the immunological argument for a COVID-19 booster this early is shaky at best," which is not necessarily a bad thing. That's because the vaccines available are still holding up well, especially against severe illness and death, and Wu clarifies that breakthrough symptomatic infections, while increasing, are still uncommon.
Ali Ellebedy, an immunologist at Washington University in St. Louis, told Wu that people's immune systems should remember the coronavirus, including the Delta variant, for some time. Therefore, boosters may not make that much of a difference, at least until there's evidence that they lead to the long-term, durable antibody production Gottlieb mentioned as opposed to a "boom-and-bust cycle." Read more at The Atlantic.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Codeword: April 17, 2024
The Week's daily codeword puzzle
By The Week Staff Published
-
The growing thirst for camel milk
Under the radar Climate change and health-conscious consumers are pushing demand for nutrient-rich product – and the growth of industrialised farming
By Harriet Marsden, The Week UK Published
-
'Good riddance to the televised presidential debate'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published